InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
80%
T+90 mean return
-1.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Richard Stephen, Director. Officer active across 2 companies, notably Anika Therapeutics, Inc.. In total, 7 reports have been published. History available since 16 June 2021. The latest transaction was filed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
10,402 sharesCommon StockSEC:0001193125-26-279541:0
14,164 shares0Common StockSEC:0001171843-25-004071:0
5,771 shares0Common StockSEC:0001171843-24-003909:0
6,500 shares0Common StockSEC:0001171843-23-003961:0
7,954 shares0Common StockSEC:0001171843-22-004301:0
4,172 shares0Common StockSEC:0001171843-21-004429
4,172 shares0Common StockSEC:0001171843-21-004429:0
7 of 7 declarations
About Richard Stephen
Richard Stephen is a Board Member at Anika Therapeutics, Inc. He brings valuable experience in the biopharmaceutical sector, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.
